Vetter a winner of the Fraunhofer Clean Manufacturing Award CLEAN! 2018
Vetter innovations in aseptic production increases the competitiveness of its customers.
Vetter is one of the winners of the clean manufacturing award CLEAN! 2018. The pharmaceutical service provider was able to convince the independent expert jury of the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) with its innovative Vetter CleanRoom Technology V-CRT. The prize was awarded as part of the LOUNGES 2018, an associated trade event in the clean manufacturing sector.
With the CLEAN! award, the Fraunhofer IPA honors groundbreaking developments in clean technology. "The production of active pharmaceutical ingredients, microchips or nanoproducts would be unthinkable without a high-purity manufacturing environment," says Dr.-Ing. Udo Gommel, Head of Department Fraunhofer IPA. "Vetter drives innovations in aseptic production and thereby increases the competitiveness of its customers. This achievement is honored by the Fraunhofer clean manufacturing award CLEAN! 2018." Important award and evaluation criteria included innovation leap, sustainability and industrial feasibility of the application concept. The Fraunhofer IPA is an institution of the Fraunhofer-Gesellschaft, Munich, that promotes applied research. It is particularly concerned with the development of sustainable and pioneering products.
Bernd Stauss, Senior Vice President Production/Engineering at Vetter, says: "We continue to develop our technologies to meet the complex and ever-increasing demands for quality and flexibility in pharmaceutical manufacturing. We are very pleased that this has now been honored with the Fraunhofer clean manufacturing award CLEAN! 2018 for our cleanroom concept V-CRT."
V-CRT is a holistic manufacturing technology developed by Vetter for the safe aseptic filling of injection systems. The innovative approach combines the advantages of isolators with Restricted Access Barrier Systems (RABS) and is based on the idea of fully automated decontamination of the entire cleanroom with hydrogen peroxide (H2O2). The result is the highest possible safety in the prevention of contamination as well as a flexible production process. Following the successful commercial implementation and validation of V-CRT in 2017, the technology will be used in all cleanrooms at Vetter by 2025.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance